Compliance issues in quality of life assessment: experiences of two Cancer Research Campaign sponsored groups.
Fallowfield
L
L
CRC Psychosocial Oncology Group, Department of Oncology, University College Hospital Medical School, London, U.K.
D000970:Antineoplastic Agents / Q000627:therapeutic use; D018890:Chemoprevention; D017326:Clinical Trials, Phase III as Topic / Q000379:methods*; D003625:Data Collection / Q000379:methods*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008408:Mastectomy / Q000523:psychology; D009369:Neoplasms / Q000517:prevention & control / Q000523:psychology* / Q000601:surgery; D010349:Patient Compliance; D011788:Quality of Life; D012107:Research Design; D011795:Surveys and Questionnaires; D013629:Tamoxifen / Q000627:therapeutic use; D006113:United Kingdom
D000970:Antineoplastic Agents; D013629:Tamoxifen